Status of COVID-19 Medicines and Active Pharmaceutical Ingredients (APIs) updated M Announcement 1 June, 2022 - 13:00 (CEST)
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 31 May, 2022 - 20:10 (CEST)
Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process updated V Alerts 26 May, 2022 - 15:00 (CEST)
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 25 May, 2022 - 14:00 (CEST)
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 24 May, 2022 - 20:30 (CEST)
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 18 May, 2022 - 14:20 (CEST)
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 16 May, 2022 - 19:30 (CEST)
List of IVDs that have received WHO Emergency Use Listing for SARS-CoV-2 updated IVD Announcement 16 May, 2022 - 18:00 (CEST)
First isoniazid/rifapentine generic prequalified M Announcement 13 May, 2022 - 15:30 (CEST) WHO Prequalification Unit (PQT) added the below new product to its prequalified list: